Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)
Table 6
Subgroup analyses according to BMI—mean ± SE ().
NGT ()
HINS ()
IGT ()
T2DM ()
Nonobesity ()
Overweight ()
Obesity ()
Nonobesity ()
Overweight ()
Obesity ()
Nonobesity ()
Overweight ()
Obesity ()
Weight (Kg)
62.20 ± 6.75
63.38 ± 4.23
76.04 ± 6.64
91.50 ± 12.80
63.50 ± 3.63
72.63 ± 7.56
91.50 ± 9.57
62.43 ± 8.94
71.38 ± 4.25
90.42 ± 7.872
BMI (kg/m2)
22.41 ± 1.54
22.90 ± 0.65
26.39 ± 0.88
32.66 ± 1.56
22.72 ± 0.58
25.98 ± 1.39
31.32 ± 2.05
2.88 ± 0.81
26.05 ± 1.29
31.57 ± 2.29
Waist (cm)
76.75 ± 7.72
77.75 ± 9.11
88.50 ± 6.76
102.25 ± 7.39
77.88 ± 6.43
89.46 ± 5.53
99.61 ± 7.79
82.29 ± 5.09
90.08 ± 4.40
105.83 ± 6.05
TG (mmol/L)
1.24 ± 0.73
2.13 ± 1.12
2.67 ± 1.64
2.14 ± 1.30
1.33 ± 0.81
1.88 ± 1.31
2.59 ± 0.90
1.31 ± 0.54
1.80 ± 0.81
2.26 ± 0.87
HDL (mmol/L)
1.62 ± 0.35
1.36 ± 0.19
1.41 ± 0.38
1.35 ± 0.29
1.34 ± 0.18
1.32 ± 0.48
1.04 ± 0.23
1.20 ± 0.16
1.06 ± 0.20
0.88 ± 0.15
FINS (mU/L)
5.29 ± 4.61
6.25 ± 1.64
11.39 ± 5.99
15.45 ± 5.82
7.20 ± 4.94
10.16 ± 6.04
16.21 ± 6.56
3.52 ± 0.88
9.91 ± 6.996
12.701 ± 6.31
value
Matsuda index
13.16 ± 7.24
6.28 ± 0.49
4.88 ± 2.26
4.12 ± 1.50
10.92 ± 4.64
6.57 ± 2.97
4.11 ± 2.41
10.20 ± 3.21
5.29 ± 2.57
3.54 ± 1.24
Notes: comparison among HINS, IGT, and T2DM groups, , compared with nonobesity subgroups and , compared with overweight subgroups.